Commercial DNA Testing May Cause Harm, Scientific Studies Show (If You Read Through to the Study Limitations at the End)
By Cecile Janssens,
Huffington Post
| 12. 22. 2014
Untitled Document
A year after the US Food and Drug Administration urged 23andMe to stop the marketing of its personal genome test in the United States, the world's largest direct-to-consumer genetics company relaunched the test in Canada and the United Kingdom.
"Find out how your genetics relate to things like abnormal blood clotting, cystic fibrosis or response to certain medications." [italics added] "Keep in mind that many conditions and traits are influenced by multiple factors. Our reports are intended for informational purposes only and do not diagnose disease or illness."
The UK website of 23andMe opens with clarifying statements about how the company wants us to see their renewed test. "The UK Medicines and Healthcare Products Regulatory Agency ... has determined that we're not a medical product, more an information product," says 23andMe's CEO Anne Wojcicki in The Guardian.
As it seems, 23andMe has relaunched its DNA test as the information service it was in the beginning: a service that offers a personalized exploration about what science knows about your genes, how they relate to your health and what...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jonquilyn Hill, Vox | 10.18.2026
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...